Sound View Wealth Advisors Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.03M Sell
28,880
-752
-3% -$105K 0.27% 84
2025
Q4
$3.64M Buy
29,632
+70
+0.2% +$8.51K 0.24% 90
2025
Q3
$3.28M Buy
29,562
+2,428
+9% +$276K 0.23% 99
2025
Q2
$3.01M Buy
27,134
+17,007
+168% +$1.81M 0.22% 101
2025
Q1
$1.13M Sell
10,127
-684
-6% -$70.6K 0.09% 163
2024
Q4
$999K Buy
10,811
+271
+3% +$24.4K 0.08% 175
2024
Q3
$884K Buy
10,540
+906
+9% +$69.1K 0.07% 194
2024
Q2
$661K Buy
9,634
+608
+7% +$40.6K 0.07% 208
2024
Q1
$661K Sell
9,026
-409
-4% -$31.5K 0.07% 212
2023
Q4
$764K Buy
9,435
+1,343
+17% +$105K 0.08% 191
2023
Q3
$606K Buy
8,092
+352
+5% +$27.1K 0.08% 197
2023
Q2
$597K Sell
7,740
-1,112
-13% -$88.7K 0.08% 197
2023
Q1
$734K Sell
8,852
-583
-6% -$48.3K 0.1% 178
2022
Q4
$764K Buy
9,435
+3,369
+56% +$267K 0.08% 191
2022
Q3
$374K Sell
6,066
-71
-1% -$4.48K 0.08% 186
2022
Q2
$379K Sell
6,137
-5
-0.1% -$310 0.08% 192
2022
Q1
$365K Buy
6,142
+599
+11% +$38.3K 0.07% 210
2021
Q4
$402K Buy
5,543
+1,136
+26% +$78.2K 0.08% 197
2021
Q3
$308K Sell
4,407
-1,045
-19% -$73.4K 0.06% 229
2021
Q2
$375K Buy
5,452
+684
+14% +$45.7K 0.08% 204
2021
Q1
$308K Buy
4,768
+1,149
+32% +$74.1K 0.07% 214
2020
Q4
$211K Sell
3,619
-260
-7% -$15.7K 0.05% 241
2020
Q3
$245K Buy
3,879
+973
+33% +$67.5K 0.06% 219
2020
Q2
$224K Buy
+2,906
New +$223K 0.06% 220

Other funds holding GILD

Sound View Wealth Advisors Group's GILD Position: Q1 2026 in Review

Sound View Wealth Advisors Group reduced its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, selling an estimated $105K and leaving 28,880 shares worth $4.03M. The position accounts for 0.27% of the portfolio, ranked #84.

Sound View Wealth Advisors Group first reported a position in GILD in Q2 2020 and has held it in 24 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sound View Wealth Advisors Group held 28,880 shares of Gilead Sciences worth $4.03M as of Q1 2026.
  • Sound View Wealth Advisors Group sold 752 Gilead Sciences shares in Q1 2026, an estimated $105K.
  • Gilead Sciences made up 0.27% of Sound View Wealth Advisors Group's portfolio in Q1 2026, its #84 holding.
  • Sound View Wealth Advisors Group first reported a position in Gilead Sciences in Q2 2020 and has held it in 24 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q1 2026, filed 6 May 2026.